PM360 asked experts who know how to improve medication adherence about the new challenges that COVID-19 will bring and what other barriers companies should pay particular attention to. More precisely, we asked them:
- How will the COVID-19 pandemic impact patient adherence? How can companies address short-term effects such as an inability to see their doctor, pick up prescriptions, or pay for medication? And what longer term impact on adherence and potential solutions to address it we will see even after more shelter-in-place orders are lifted?
- What barriers to adherence are not being addressed as much as they should? How can pharma better help patients to address these barriers? And what ways can pharma better work with patients to discover these unmet needs?
OptimizeRx's Steve Silvestro weighs in on these questions. Read full article here.
